CANDICE YANT: Open Payments
NPI 1356669584 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$924 in 49 payments from 18 companies in 2025. Trend: 2023 $244 · 2024 $1,050 · 2025 $924
Food & beverage: $924
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $191 |
| PFIZER INC. | 6 | $126 |
| Medtronic, Inc. | 1 | $65 |
| E.R. Squibb & Sons, L.L.C. | 3 | $62 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $57 |
| Regeneron Healthcare Solutions, Inc. | 3 | $55 |
| Amgen Inc. | 3 | $48 |
| Merck Sharp & Dohme LLC | 2 | $45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| HEARTFLOW, INC. | 2 | $40 |
Products named: LEQVIO, ELIQUIS, SYMPLICITY G3, Kerendia, EVKEEZA, Repatha, VERQUVO, VYNDAQEL.
Industry payments across AL — which companies pay providers there.
